Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs AskBio 009 (Primary)
- Indications Haemophilia B
- Focus Therapeutic Use
- Sponsors Baxalta
- 26 Jun 2017 Status changed from recruiting to completed.
- 21 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 May 2017.
- 13 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 May 2017.